| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 11/01/2006 | CN1282658C Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 10/31/2006 | US7129402 Hybrid maize 33N56 |
| 10/31/2006 | US7129401 Hybrid maize 39F27 |
| 10/31/2006 | US7129399 Soybean cultivar S030158 |
| 10/31/2006 | US7129394 Using DNA immobilized, glycerol-free metal microparticles to bombardment plant tissue in osmotic nutrient broth; tissue engineering and heterologous gene expression |
| 10/31/2006 | US7129343 Enhancing transcription via TATA Box census element as core of promoter |
| 10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
| 10/31/2006 | US7129223 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference |
| 10/31/2006 | US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 10/31/2006 | US7129086 Amplification of human hematopoietic stem cells; obtain stem cells, inoculate nutrient broths, culture and recover cells |
| 10/31/2006 | US7129085 Polynucleotides encoding a human leucine-rich repeat domain containing protein, HLLRCR-1 |
| 10/31/2006 | US7129082 A holder containing a three-dimensional open cell foams, with anchored live cells, an oxygen carrier liquid satarating the foam; biological apparatus for cultivating live cells |
| 10/31/2006 | US7129078 DNA encoding androgen receptor fragment |
| 10/31/2006 | US7129077 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder |
| 10/31/2006 | US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 10/31/2006 | US7129070 Targeted system for removing tumor cells from cell populations |
| 10/31/2006 | US7129063 Junction-enriched and -associated protein (JEAP); antibodies for visualizing localization |
| 10/31/2006 | US7129062 Matrix attachment regions and methods for use thereof |
| 10/31/2006 | US7129061 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand or "TRELL", a polypeptide which is a member of the Tumor Necrosis Factor Family |
| 10/31/2006 | US7129057 Human testis specific serine/threonine kinase 3 |
| 10/31/2006 | US7129055 Detection of translocation protein in sample; obtain tissue sample, incubate with binding agent, detect binding activity, presence of bound agent indicates presence of translocation protein |
| 10/31/2006 | US7129037 Delivering antigen to dendritic cells by contacting dendritic cells with apopototic cells expressing an antigen to allow antigen to be internalized by the dendritic cells, and wherein apoptotic cells have been induced in vitro to become apoptotic |
| 10/31/2006 | US7129035 Method of preserving tissue |
| 10/31/2006 | US7129034 Culturing stem cell with fibroblast growth factor and epidermal growth factor |
| 10/31/2006 | US7128906 T1 receptor-like ligand II and uses thereof |
| 10/31/2006 | CA2336561C Monoclonal antibody to lymphocyte-associated cell surface protein |
| 10/31/2006 | CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 10/31/2006 | CA2250047C Monoclonal antibodies binding human growth hormone (hgh) |
| 10/31/2006 | CA2239729C Cell separation composition, kit and method |
| 10/31/2006 | CA2180830C Anti-annexin-v monoclonal antibody, process for producing the same, and use thereof |
| 10/31/2006 | CA2162677C Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 10/26/2006 | WO2006113914A2 Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms |
| 10/26/2006 | WO2006113881A2 Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood |
| 10/26/2006 | WO2006113861A2 Mammalian expression systems |
| 10/26/2006 | WO2006113731A2 Bone marrow-derived neurogenic cells and uses thereof |
| 10/26/2006 | WO2006113647A2 Recovery of tissue function following administration of b cells to injured tissue |
| 10/26/2006 | WO2006113629A1 Chemically defined culture media for expansion and differentiation of epidermal cells and uses thereof for in vitro growth of hair follicles |
| 10/26/2006 | WO2006113534A1 Immortilization of cells including neuronal cells |
| 10/26/2006 | WO2006113487A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 10/26/2006 | WO2006113382A2 Bioreactor system and method of enhancing functionality of muscle cultured in vitro |
| 10/26/2006 | WO2006113214A2 Vaccine against pandemic strains of influenza viruses |
| 10/26/2006 | WO2006113181A2 Stem-like cells in bone sarcomas |
| 10/26/2006 | WO2006112869A2 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 10/26/2006 | WO2006112734A1 Choroid plexus preparation and uses thereof |
| 10/26/2006 | WO2006112684A1 Transplantation of differentiated immature adipocytes and biodegradable scaffold for tissue augmentation |
| 10/26/2006 | WO2006112588A1 Method for activating cd4 t cells |
| 10/26/2006 | WO2006112587A1 Method for activating cd8 t cells |
| 10/26/2006 | WO2006112418A1 Screening system for substance inhibiting inflammatory change of adipocyte and screening method using the same |
| 10/26/2006 | WO2006112390A1 Fat-derived progenitor cell and use thereof |
| 10/26/2006 | WO2006112327A1 Lk3 gene regulating rice grain length and the use thereof |
| 10/26/2006 | WO2006112238A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 10/26/2006 | WO2006112040A1 NOVEL β-GALACOTSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD OF PRODUCING THE SAME |
| 10/26/2006 | WO2006112025A1 NOVEL β-GALACTOSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 10/26/2006 | WO2006111998A1 Recombinant adenoviral vector for the expression of mdm family proteins and uses thereof |
| 10/26/2006 | WO2006111722A1 Polymeric biomaterial for cell growth and differentiation |
| 10/26/2006 | WO2006111711A1 A method for producing a nitrogen functionalised surface |
| 10/26/2006 | WO2006111706A1 Cytotrophoblast stem cell |
| 10/26/2006 | WO2006110950A1 In vivo model for preclinical drug development |
| 10/26/2006 | WO2006097701A3 Skin equivalent culture |
| 10/26/2006 | WO2006050330B1 Platelets from stem cells |
| 10/26/2006 | WO2006031779A3 Promoter molecules for use in plants |
| 10/26/2006 | WO2006024966A3 Three-dimensional self assembly in suspension of adherent cells |
| 10/26/2006 | WO2005099758A3 Injectable bioartificial tissue matrix |
| 10/26/2006 | WO2005095625A8 Arabinogalactan protein compositions and methods for fostering somatic embryogenic competence |
| 10/26/2006 | WO2005086938A3 Artificial mutation controls for diagnostic testing |
| 10/26/2006 | WO2005041891A3 Neutrophil activation by immune response modifier compounds |
| 10/26/2006 | WO2005011599A3 Antibodies specific for toxic amyloid beta protein oligomers |
| 10/26/2006 | WO2003093789A3 Method for measuring ion channel activity |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | WO2002078420A3 Molecules for disease detection and treatment |
| 10/26/2006 | US20060242739 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 10/26/2006 | US20060242738 Polynucleotides and polypeptides in plants |
| 10/26/2006 | US20060242737 Modulation of flowering time by the pft1 locus |
| 10/26/2006 | US20060242736 Dissimilar promoters for gene suppression |
| 10/26/2006 | US20060242735 Nucleic acid fragments encoding isoflavone synthase |
| 10/26/2006 | US20060242734 Insecticidal polypeptides and methods of use thereof |
| 10/26/2006 | US20060242733 transformed plant comprising in its genome a stably incorporated nucleotide construct containing a nucleotide sequence that encodes a polypeptide that is pesticidal for pest belonging to the order Lepidoptera, coding sequence is operably linked to a promoter that drive expression in a plant cell |
| 10/26/2006 | US20060242732 encode pesticidal proteins; transgenic pest resistant plants |
| 10/26/2006 | US20060242731 DNA shuffling to produce herbicide selective crops |
| 10/26/2006 | US20060242730 Methods and compositions for tobacco plants with reduced nitrosamines |
| 10/26/2006 | US20060242729 Polynucleotides encoding proteins involved in plant metabolism |
| 10/26/2006 | US20060242728 Chemically-inducible promotors for the expression of proteins in plants |
| 10/26/2006 | US20060242727 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicde-tolerant plants containing it |
| 10/26/2006 | US20060242726 Methods and vectors for making knockout animals |
| 10/26/2006 | US20060242723 Chimeric mouse with regulated bradeion gene expression |
| 10/26/2006 | US20060242722 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells |
| 10/26/2006 | US20060242720 Inducible site-directed mutagenesis through conditional gene rescue |
| 10/26/2006 | US20060242717 Expression systems |
| 10/26/2006 | US20060241756 Cartilage replacement implant and method for producing a cartilage replacement implant |
| 10/26/2006 | US20060241139 Treatment of DNA damage related disorders |
| 10/26/2006 | US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity |
| 10/26/2006 | US20060241055 Peptides promoting cell adherence, growth and secretion |
| 10/26/2006 | US20060241032 Cell support comprising immobilized collagen/intergin fusion and a argine-glycine-aspartic acid (RGD) motif for use as scaffold to propagate implant or transplant materials; improving drug delivery systems; inhibition of tumor metastasis; tissue engineering |
| 10/26/2006 | US20060240556 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 10/26/2006 | US20060240555 Fibrin cell supports and method of use thereof |
| 10/26/2006 | US20060240554 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 10/26/2006 | US20060240553 Cultures of human CNS neural stem cells |
| 10/26/2006 | US20060240552 Anterior ocular-associated cell sheet, three-dimensional construct and process for producing the same |
| 10/26/2006 | US20060240551 Immunotherapy, immunogens, hybridomas |
| 10/26/2006 | US20060240550 Three-dimensional cell to tissue development process |